Rosette-Forming Glioneural Tumour (RGNT)

Rosette-forming glioneural tumours (RGNTs) are a rare central nervous system (CNS) tumour that tends to develop in the midline structures of the brain. These tumours are often benign and slow growing, however in rare cases they may become malignant. Most commonly, it develops in the fourth ventricle of the cerebrum, however, can affect other midline structures such as the spine, optic chiasm (located below the hypothalamus), and pineal gland.

The brain is a complex organ that is responsible for controlling all functions of the body. It has five main portions: the cerebrum, cerebellum, brainstem, pituitary gland, and hypothalamus. The cerebrum is the biggest part of the brain, and consists of the frontal, parietal, temporal, and occipital lobes. This part of the brain is responsible for voluntary movement, intelligence, and memory. The cerebellum is a small part of the brain located at the back of the head, and regulates posture and balance. The brainstem is a small, stalk-like structure towards the bottom of the brain that connects the brain to the spinal cord.  It regulates many vital bodily processes, such as swallowing, breathing, and heart rate. The pituitary gland is a pea sized organ located behind the eyes, and is responsible for the production and secretion of hormones in the body. The hypothalamus is located deep within the brain, and has many important functions, such as producing and secreting different hormones, regulating temperature, and controlling appetite.

The spinal cord is a long, thin, tubular structure that extends down from the brainstem to the lower back. It is made of nerve tissue, and is surrounded by the bones of the spine (vertebrae). The spinal cord is responsible for transmitting nerve signals from the brain to the body, and vice versa. It has motor functions (such as voluntary movement), sensory functions (such as pressure, touch, temperature, and pain), and autonomous functions (such as regulating digestion, heart rate, and blood pressure).

RGNTs are slightly more common in females, and tend to develop in children and young adults under 30. However, anyone can develop this disease.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, as most RGNTs are considered benign, these tumours are generally considered low-grade and are not staged.

Once your tumour has been diagnosed, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including location, age, stage of disease and overall health.

Treatment options for RGNTs may include:

  • Surgery to remove as much of the tumour as possible.
  • Shunt insertion.
  • Radiation therapy.
  • Chemotherapy.
  • Antiseizure medication.
  • Corticosteroids.
  • Immunotherapy.
  • Clinical trials.
  • Palliative care.

Risk factors

Because of how rare RGNTs are, there has been limited research done into the risk factors of this disease. However, researchers have identified a potential link between RGNTs and certain genetic conditions, including neurofibromatosis type 1 (NF1) and Tricho-rhino-phalangeal dysplasia type 1 syndrome (TRPS I).

Symptoms

The symptoms of RGNTs will often vary based on which portions of the brain and/or spine are affected. Common symptoms of RGNTs include:

  • Persistent headaches, which may increase in intensity.
  • Difficulty with balance and coordination.
  • Nausea and/or vomiting.
  • Numbness and tingling throughout the body.
  • Muscle weakness, particularly in the arms and legs.
  • Changes in vision, such as:
    • Blurred vision.
    • Double vision.
    • Worsening eyesight.
  • Neck pain.
  • Changes in hearing, such as hearing impairment or hearing loss.
  • Difficulties with speech.
  • Insomnia.
  • Fatigue.
  • Tremors, which may affect one area of the body or affect the whole body.
  • Hydrocephalus, which carries its own set of symptoms:
    • Headaches.
    • Increased intracranial pressure.
    • Nausea and/or vomiting.
    • Difficulties with eye movement.
    • Difficulties with balance.
    • Difficulties walking.
  • Seizures.
  • Dizziness.
  • Syncope.
  • Confusion.
  • Behavioural and/or personality changes.
  • Memory loss.
  • Decreased cognition.

In rare cases, the following symptoms may also appear:

  • Back pain.
  • Chest pain.
  • Pain in the arms and/or legs.
  • Difficulties with urination and/or bowel habits.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have an RGNT, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Neurological examination.
  • Lumbar puncture.
  • Imaging tests, potentially including:
    • CT (computed tomography) scan.
    • MRI (magnetic resonance imaging).
  • Blood tests.
  • Electromyogram (EMG).
  • Nerve conduction studies.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.